Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01866371 · ClinicalTrials.gov registry record
High Resolution Retinal Imaging
A clinical trial of Age-related Macular Degeneration and Retinitis Pigmentosa, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- 600
- Enrollment target
- 1
- Study location
NCT01866371 is a study of Age-related Macular Degeneration and Retinitis Pigmentosa that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 600 participants, below the 1,500-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01866371, a study of Age-related Macular Degeneration and Retinitis Pigmentosa, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
Studying the morphology and function of the normal and diseased retina in vivo is needed for advancing the detection, diagnosis, and treatment of retinal disease. This protocol uses an adaptive optics scanning laser ophthalmoscope (AOSLO) to image the normal and diseased retina with individual cellular resolution non-invasively. The primary objective of this study is to obtain and analyze high-resolution images of the retina, in particular by imaging the cone photoreceptor mosaic, the retinal vasculature and other retinal layers. The study design will involve case-control studies, where cases are followed over time. Subjects age 7 and older may be invited to participate. The main research procedure involves retinal imaging with the AOSLO. The primary endpoint is the observation of differences in retinal images between subjects with and without retinal diseases. These changes will be quantified by examining the cell density, size, spacing and regularity of the cone photoreceptor mosaic, as well as examining the differences between other retinal layers.
Conditions Studied
Interventions
- PROCEDURE Retinal imaging
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2013-05 |
| Est. Completion | 2027-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01866371
The ClinicalTrials.gov registry entry for NCT01866371 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,500-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (60% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Age-related Macular Degeneration appearing as the primary indexed condition, and to 1 intervention - of which Retinal imaging is the first listed.
NCT01866371 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01866371 about?
NCT01866371 is a clinical study titled "High Resolution Retinal Imaging". Studying the morphology and function of the normal and diseased retina in vivo is needed for advancing the detection, diagnosis, and treatment of retinal disease. This protocol uses an adaptive optics scanning laser ophthalmoscope (AOSLO) to image the normal and diseased retina with individual cellu...
What is the current status of trial NCT01866371?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2013-05. Estimated completion is 2027-12.
What conditions does trial NCT01866371 study?
This clinical trial studies the following conditions: Age-related Macular Degeneration, Retinitis Pigmentosa, Geographic Atrophy, Choroideremia, Stargardts.
What interventions are being tested in trial NCT01866371?
The interventions under investigation include: Retinal imaging (PROCEDURE).
Who is sponsoring clinical trial NCT01866371?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01866371 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Age-related Macular Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD
RECRUITING · Phase 2
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Visual Remapping to Aid Reading With Field Loss
RECRUITING · NA
-
A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RECRUITING · Phase 1
-
Effects of Goji vs. Fiber on Macular Degeneration
RECRUITING · NA
-
Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
RECRUITING · Phase 1
Explore more on PlainTrial
Age-related Macular Degeneration
All registered trials for this condition
Retinitis Pigmentosa
All registered trials for this condition
Pennsylvania
All trials with a study site in Pennsylvania
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.